Invivyd completes enrollment in Phase 3 COVID antibody trial

Markets Investing.com By Investing.com 16 Jun 2026 11:17 1 min read

Invivyd completes enrollment in Phase 3 COVID antibody trial

Invivyd completes enrollment in Phase 3 COVID antibody trial

Invivyd completes enrollment in Phase 3 COVID antibody trial

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.